This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Feb 16;190(3):e34.

doi: 10.1093/bjd/ljae029.

Outcomes that need to be assessed in pyoderma gangrenosum clinical trials

No authors listed

PMID: 38366827
DOI: 10.1093/bjd/ljae029

Editorial

Outcomes that need to be assessed in pyoderma gangrenosum clinical trials

No authors listed. Br J Dermatol. 2024.

. 2024 Feb 16;190(3):e34.

doi: 10.1093/bjd/ljae029.

PMID: 38366827
DOI: 10.1093/bjd/ljae029

No abstract available

PubMed Disclaimer

Comment on

A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
Jacobson ME, Rick JW, Gerbens LAA, Baghoomian W, Gould LJ, Marzano AV, Chen DM, Oakes DL, Dissemond J, Yamamoto T, Shinkai K, Nolan B, Lobato D, Thomas KS, Ortega-Loayza AG; UPGRADE. Jacobson ME, et al. Br J Dermatol. 2024 Feb 16;190(3):392-401. doi: 10.1093/bjd/ljad420. Br J Dermatol. 2024. PMID: 37952167

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems